Cargando…

The effects of Src tyrosine kinase inhibitor, saracatinib, on the markers of epileptogenesis in a mixed-sex cohort of adult rats in the kainic acid model of epilepsy

Neurodegeneration and neuroinflammation are key processes of epileptogenesis in temporal lobe epilepsy (TLE). A considerable number (∼30%) of patients with epilepsy are resistant to currently available antiseizure drugs and thus there is a need to develop adjunct therapies to modify disease progress...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rao, Nikhil S., Putra, Marson, Meyer, Christina, Almanza, Aida, Thippeswamy, Thimmasettappa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10665569/ https://www.ncbi.nlm.nih.gov/pubmed/38025259 http://dx.doi.org/10.3389/fnmol.2023.1294514

Ejemplares similares

Saracatinib, a Src Tyrosine Kinase Inhibitor, as a Disease Modifier in the Rat DFP Model: Sex Differences, Neurobehavior, Gliosis, Neurodegeneration, and Nitro-Oxidative Stress
por: Gage, Meghan, et al.
Publicado: (2021)

Mechanisms of disease-modifying effect of saracatinib (AZD0530), a Src/Fyn tyrosine kinase inhibitor, in the rat kainate model of temporal lobe epilepsy
por: Sharma, Shaunik, et al.
Publicado: (2021)

DFP-Induced Status Epilepticus Severity in Mixed-Sex Cohorts of Adult Rats Housed in the Same Room: Behavioral and EEG Comparisons
por: Rao, Nikhil S., et al.
Publicado: (2022)

Fyn-tau Ablation Modifies PTZ-Induced Seizures and Post-seizure Hallmarks of Early Epileptogenesis
por: Putra, Marson, et al.
Publicado: (2020)

Differential Impact of Severity and Duration of Status Epilepticus, Medical Countermeasures, and a Disease-Modifier, Saracatinib, on Brain Regions in the Rat Diisopropylfluorophosphate Model
por: Gage, Meghan, et al.
Publicado: (2021)

Gut dysbiosis following organophosphate, diisopropylfluorophosphate (DFP), intoxication and saracatinib oral administration
por: Gage, Meghan, et al.
Publicado: (2022)

Soman (GD) Rat Model to Mimic Civilian Exposure to Nerve Agent: Mortality, Video-EEG Based Status Epilepticus Severity, Sex Differences, Spontaneously Recurring Seizures, and Brain Pathology
por: Gage, Meghan, et al.
Publicado: (2022)

Exploring the benefits of in-diet versus repeated oral dosing of saracatinib (AZD0530) in chronic studies: insights into pharmacokinetics and animal welfare
por: Vasanthi, Suraj S., et al.
Publicado: (2023)

Diurnal burden of spontaneous seizures in early epileptogenesis in the post‐kainic acid rat model of epilepsy
por: Mizuno, Stephanie, et al.
Publicado: (2021)

Peripheral and central effects of NADPH oxidase inhibitor, mitoapocynin, in a rat model of diisopropylfluorophosphate (DFP) toxicity
por: Meyer, Christina, et al.
Publicado: (2023)

Myo-Inositol Limits Kainic Acid-Induced Epileptogenesis in Rats
por: Kandashvili, Manana, et al.
Publicado: (2022)

Disease-Modifying Effects of a Glial-targeted Inducible Nitric Oxide Synthase Inhibitor (1400W) in Mixed-sex Cohorts of a Rat Soman (GD) Model of Epilepsy
por: Vasanthi, Suraj S., et al.
Publicado: (2023)

Disease-modifying effects of a glial-targeted inducible nitric oxide synthase inhibitor (1400W) in mixed-sex cohorts of a rat soman (GD) model of epilepsy
por: Vasanthi, Suraj S., et al.
Publicado: (2023)

SRC kinase inhibition with saracatinib limits the development of osteolytic bone disease in multiple myeloma
por: Heusschen, Roy, et al.
Publicado: (2016)

Combating head and neck cancer metastases by targeting Src using multifunctional nanoparticle-based saracatinib
por: Lang, Liwei, et al.
Publicado: (2018)

Targeting Src family kinase member Fyn by Saracatinib attenuated liver fibrosis in vitro and in vivo
por: Du, Guifang, et al.
Publicado: (2020)

The Impacts of Surgery and Intracerebral Electrodes in C57BL/6J Mouse Kainate Model of Epileptogenesis: Seizure Threshold, Proteomics, and Cytokine Profiles
por: Tse, Karen, et al.
Publicado: (2021)

Characterization of Cortical Glial Scars in the Diisopropylfluorophosphate (DFP) Rat Model of Epilepsy
por: Gage, Meghan, et al.
Publicado: (2022)

Sex‐based structural and functional MRI outcomes in the rat brain after soman (GD) exposure‐induced status epilepticus
por: Gage, Meghan, et al.
Publicado: (2023)

Seizure-Induced Oxidative Stress in Temporal Lobe Epilepsy
por: Puttachary, Sreekanth, et al.
Publicado: (2015)

Immediate Epileptogenesis after Kainate-Induced Status Epilepticus in C57BL/6J Mice: Evidence from Long Term Continuous Video-EEG Telemetry
por: Puttachary, Sreekanth, et al.
Publicado: (2015)

Long-Term Effects of Myoinositol on Behavioural Seizures and Biochemical Changes Evoked by Kainic Acid Induced Epileptogenesis
por: Tsverava, Lia, et al.
Publicado: (2019)

Simultaneously inactivating Src and AKT by saracatinib/capivasertib co-delivery nanoparticles to improve the efficacy of anti-Src therapy in head and neck squamous cell carcinoma
por: Lang, Liwei, et al.
Publicado: (2019)

The Kainic Acid Models of Temporal Lobe Epilepsy
por: Rusina, Evgeniia, et al.
Publicado: (2021)

Exploratory Metabolomics Profiling in the Kainic Acid Rat Model Reveals Depletion of 25-Hydroxyvitamin D3 during Epileptogenesis
por: Heischmann, Svenja, et al.
Publicado: (2016)

An exploratory randomized-controlled trial of the efficacy of the Src-kinase inhibitor saracatinib as a novel analgesic for cancer-induced bone pain
por: Danson, Sarah, et al.
Publicado: (2019)

Neuroimaging Biomarkers of Experimental Epileptogenesis and Refractory Epilepsy
por: Reddy, Sandesh D., et al.
Publicado: (2019)

Epileptogenesis following Kainic Acid-Induced Status Epilepticus in Cyclin D2 Knock-Out Mice with Diminished Adult Neurogenesis
por: Kondratiuk, Ilona, et al.
Publicado: (2015)

1400 W, a selective inducible nitric oxide synthase inhibitor, mitigates early neuroinflammation and nitrooxidative stress in diisopropylfluorophosphate-induced short-term neurotoxicity rat model
por: Massey, Nyzil, et al.
Publicado: (2023)

Importance of the novel organic cation transporter 1 for tyrosine kinase inhibition by saracatinib in rheumatoid arthritis synovial fibroblasts
por: Harrach, Saliha, et al.
Publicado: (2017)

MiR-324-5p inhibition after intrahippocampal kainic acid-induced status epilepticus does not prevent epileptogenesis in mice
por: McGann, Amanda M., et al.
Publicado: (2023)

Antithyroid Antibodies Are Implicated in Epileptogenesis of Adult Patients With Epilepsy
por: Tsai, Meng-Han, et al.
Publicado: (2015)

Dynamics of AMPA receptors regulate epileptogenesis in patients with epilepsy
por: Eiro, Tsuyoshi, et al.
Publicado: (2023)

Saracatinib is an efficacious clinical candidate for fibrodysplasia ossificans progressiva
por: Williams, Eleanor, et al.
Publicado: (2021)

Saracatinib synergizes with enzalutamide to downregulate AR activity in CRPC
por: White, Ralph E., et al.
Publicado: (2023)

Biomarker-driven trial in metastatic pancreas cancer: feasibility in a multicenter study of saracatinib, an oral Src inhibitor, in previously treated pancreatic cancer
por: Arcaroli, John, et al.
Publicado: (2012)

Aromatase inhibition plus/minus Src inhibitor saracatinib (AZD0530) in advanced breast cancer therapy (ARISTACAT): a randomised phase II study
por: Oswald, Ailsa J., et al.
Publicado: (2023)

Antiepileptic effects of exogenous β-hydroxybutyrate on kainic acid-induced epilepsy
por: Si, Jianping, et al.
Publicado: (2020)

Combination antioxidant therapy prevents epileptogenesis and modifies chronic epilepsy
por: Shekh-Ahmad, Tawfeeq, et al.
Publicado: (2019)

An EMT spectrum defines an anoikis-resistant and spheroidogenic intermediate mesenchymal state that is sensitive to e-cadherin restoration by a src-kinase inhibitor, saracatinib (AZD0530)
por: Huang, R Y-J, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_upmj9m3niu7cd7gq4tkjckivde